Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Microarray Analysis of Gene Expression and Identification of Progenitor Cells in Lung Carcinoma
Microarray Analysis of Gene Expression and Identification of Progenitor Cells in Lung Carcinoma
Status: Enrolling
Updated:  7/2/2010
Stanford University School of Medicine
mi
from
Stanford, CA
Microarray Analysis of Gene Expression and Identification of Progenitor Cells in Lung Carcinoma
Microarray Analysis of Gene Expression and Identification of Progenitor Cells in Lung Carcinoma
Status: Enrolling
Updated: 7/2/2010
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Treatment of Unresectable Hepatocellular Cancer With Opioid Growth Factor
Treatment of Unresectable Hepatocellular Cancer With Opioid Growth Factor: a Phase I Study
Status: Enrolling
Updated:  7/13/2010
Penn State Hershey Medical Center
mi
from
Hershey, PA
Treatment of Unresectable Hepatocellular Cancer With Opioid Growth Factor
Treatment of Unresectable Hepatocellular Cancer With Opioid Growth Factor: a Phase I Study
Status: Enrolling
Updated: 7/13/2010
Penn State Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURB
An Open, Non-interventional, Retrospective, Comparative, Multicenter Follow-up Study in Patients Included in the Previously Completed Clinical Study pc b305/04, to Assess a Longer-term Recurrence Rates in Patients After Hexvix® (Cysview®)Fluorescence Cystoscopy/Turb or White Light Cystoscopy/TURB
Status: Enrolling
Updated:  7/19/2010
Stanford Cancer Center, Department of Urology
mi
from
Stanford, CA
Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURB
An Open, Non-interventional, Retrospective, Comparative, Multicenter Follow-up Study in Patients Included in the Previously Completed Clinical Study pc b305/04, to Assess a Longer-term Recurrence Rates in Patients After Hexvix® (Cysview®)Fluorescence Cystoscopy/Turb or White Light Cystoscopy/TURB
Status: Enrolling
Updated: 7/19/2010
Stanford Cancer Center, Department of Urology
mi
from
Stanford, CA
Click here to add this to my saved trials
Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURB
An Open, Non-interventional, Retrospective, Comparative, Multicenter Follow-up Study in Patients Included in the Previously Completed Clinical Study pc b305/04, to Assess a Longer-term Recurrence Rates in Patients After Hexvix® (Cysview®)Fluorescence Cystoscopy/Turb or White Light Cystoscopy/TURB
Status: Enrolling
Updated:  7/19/2010
V.A. Medical Center
mi
from
Gainesville, FL
Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURB
An Open, Non-interventional, Retrospective, Comparative, Multicenter Follow-up Study in Patients Included in the Previously Completed Clinical Study pc b305/04, to Assess a Longer-term Recurrence Rates in Patients After Hexvix® (Cysview®)Fluorescence Cystoscopy/Turb or White Light Cystoscopy/TURB
Status: Enrolling
Updated: 7/19/2010
V.A. Medical Center
mi
from
Gainesville, FL
Click here to add this to my saved trials
Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURB
An Open, Non-interventional, Retrospective, Comparative, Multicenter Follow-up Study in Patients Included in the Previously Completed Clinical Study pc b305/04, to Assess a Longer-term Recurrence Rates in Patients After Hexvix® (Cysview®)Fluorescence Cystoscopy/Turb or White Light Cystoscopy/TURB
Status: Enrolling
Updated:  7/19/2010
University of Miami School of Medicine
mi
from
Miami, FL
Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURB
An Open, Non-interventional, Retrospective, Comparative, Multicenter Follow-up Study in Patients Included in the Previously Completed Clinical Study pc b305/04, to Assess a Longer-term Recurrence Rates in Patients After Hexvix® (Cysview®)Fluorescence Cystoscopy/Turb or White Light Cystoscopy/TURB
Status: Enrolling
Updated: 7/19/2010
University of Miami School of Medicine
mi
from
Miami, FL
Click here to add this to my saved trials
Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURB
An Open, Non-interventional, Retrospective, Comparative, Multicenter Follow-up Study in Patients Included in the Previously Completed Clinical Study pc b305/04, to Assess a Longer-term Recurrence Rates in Patients After Hexvix® (Cysview®)Fluorescence Cystoscopy/Turb or White Light Cystoscopy/TURB
Status: Enrolling
Updated:  7/19/2010
South Florida Clinical Research Center, Inc.
mi
from
Pembroke Pines, FL
Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURB
An Open, Non-interventional, Retrospective, Comparative, Multicenter Follow-up Study in Patients Included in the Previously Completed Clinical Study pc b305/04, to Assess a Longer-term Recurrence Rates in Patients After Hexvix® (Cysview®)Fluorescence Cystoscopy/Turb or White Light Cystoscopy/TURB
Status: Enrolling
Updated: 7/19/2010
South Florida Clinical Research Center, Inc.
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURB
An Open, Non-interventional, Retrospective, Comparative, Multicenter Follow-up Study in Patients Included in the Previously Completed Clinical Study pc b305/04, to Assess a Longer-term Recurrence Rates in Patients After Hexvix® (Cysview®)Fluorescence Cystoscopy/Turb or White Light Cystoscopy/TURB
Status: Enrolling
Updated:  7/19/2010
The Emory Clinic, Dept of Urology
mi
from
Atlanta, GA
Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURB
An Open, Non-interventional, Retrospective, Comparative, Multicenter Follow-up Study in Patients Included in the Previously Completed Clinical Study pc b305/04, to Assess a Longer-term Recurrence Rates in Patients After Hexvix® (Cysview®)Fluorescence Cystoscopy/Turb or White Light Cystoscopy/TURB
Status: Enrolling
Updated: 7/19/2010
The Emory Clinic, Dept of Urology
mi
from
Atlanta, GA
Click here to add this to my saved trials
Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURB
An Open, Non-interventional, Retrospective, Comparative, Multicenter Follow-up Study in Patients Included in the Previously Completed Clinical Study pc b305/04, to Assess a Longer-term Recurrence Rates in Patients After Hexvix® (Cysview®)Fluorescence Cystoscopy/Turb or White Light Cystoscopy/TURB
Status: Enrolling
Updated:  7/19/2010
Boston University School of Medicine
mi
from
Boston, MA
Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURB
An Open, Non-interventional, Retrospective, Comparative, Multicenter Follow-up Study in Patients Included in the Previously Completed Clinical Study pc b305/04, to Assess a Longer-term Recurrence Rates in Patients After Hexvix® (Cysview®)Fluorescence Cystoscopy/Turb or White Light Cystoscopy/TURB
Status: Enrolling
Updated: 7/19/2010
Boston University School of Medicine
mi
from
Boston, MA
Click here to add this to my saved trials
Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURB
An Open, Non-interventional, Retrospective, Comparative, Multicenter Follow-up Study in Patients Included in the Previously Completed Clinical Study pc b305/04, to Assess a Longer-term Recurrence Rates in Patients After Hexvix® (Cysview®)Fluorescence Cystoscopy/Turb or White Light Cystoscopy/TURB
Status: Enrolling
Updated:  7/19/2010
Urologic Clinical Research Unit, Gonda 7102, Mayo Clinic Rochester
mi
from
Rochester, MN
Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURB
An Open, Non-interventional, Retrospective, Comparative, Multicenter Follow-up Study in Patients Included in the Previously Completed Clinical Study pc b305/04, to Assess a Longer-term Recurrence Rates in Patients After Hexvix® (Cysview®)Fluorescence Cystoscopy/Turb or White Light Cystoscopy/TURB
Status: Enrolling
Updated: 7/19/2010
Urologic Clinical Research Unit, Gonda 7102, Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURB
An Open, Non-interventional, Retrospective, Comparative, Multicenter Follow-up Study in Patients Included in the Previously Completed Clinical Study pc b305/04, to Assess a Longer-term Recurrence Rates in Patients After Hexvix® (Cysview®)Fluorescence Cystoscopy/Turb or White Light Cystoscopy/TURB
Status: Enrolling
Updated:  7/19/2010
Hackensack University Medical Center
mi
from
Hackensack, NJ
Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURB
An Open, Non-interventional, Retrospective, Comparative, Multicenter Follow-up Study in Patients Included in the Previously Completed Clinical Study pc b305/04, to Assess a Longer-term Recurrence Rates in Patients After Hexvix® (Cysview®)Fluorescence Cystoscopy/Turb or White Light Cystoscopy/TURB
Status: Enrolling
Updated: 7/19/2010
Hackensack University Medical Center
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURB
An Open, Non-interventional, Retrospective, Comparative, Multicenter Follow-up Study in Patients Included in the Previously Completed Clinical Study pc b305/04, to Assess a Longer-term Recurrence Rates in Patients After Hexvix® (Cysview®)Fluorescence Cystoscopy/Turb or White Light Cystoscopy/TURB
Status: Enrolling
Updated:  7/19/2010
Mount Sinai Medical Center, Department of Urology
mi
from
New York, NY
Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURB
An Open, Non-interventional, Retrospective, Comparative, Multicenter Follow-up Study in Patients Included in the Previously Completed Clinical Study pc b305/04, to Assess a Longer-term Recurrence Rates in Patients After Hexvix® (Cysview®)Fluorescence Cystoscopy/Turb or White Light Cystoscopy/TURB
Status: Enrolling
Updated: 7/19/2010
Mount Sinai Medical Center, Department of Urology
mi
from
New York, NY
Click here to add this to my saved trials
Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURB
An Open, Non-interventional, Retrospective, Comparative, Multicenter Follow-up Study in Patients Included in the Previously Completed Clinical Study pc b305/04, to Assess a Longer-term Recurrence Rates in Patients After Hexvix® (Cysview®)Fluorescence Cystoscopy/Turb or White Light Cystoscopy/TURB
Status: Enrolling
Updated:  7/19/2010
URMC
mi
from
Rochester, NY
Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURB
An Open, Non-interventional, Retrospective, Comparative, Multicenter Follow-up Study in Patients Included in the Previously Completed Clinical Study pc b305/04, to Assess a Longer-term Recurrence Rates in Patients After Hexvix® (Cysview®)Fluorescence Cystoscopy/Turb or White Light Cystoscopy/TURB
Status: Enrolling
Updated: 7/19/2010
URMC
mi
from
Rochester, NY
Click here to add this to my saved trials
Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURB
An Open, Non-interventional, Retrospective, Comparative, Multicenter Follow-up Study in Patients Included in the Previously Completed Clinical Study pc b305/04, to Assess a Longer-term Recurrence Rates in Patients After Hexvix® (Cysview®)Fluorescence Cystoscopy/Turb or White Light Cystoscopy/TURB
Status: Enrolling
Updated:  7/19/2010
Thomas Jefferson Medical College, Department of Neurology
mi
from
Philadelphia, PA
Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURB
An Open, Non-interventional, Retrospective, Comparative, Multicenter Follow-up Study in Patients Included in the Previously Completed Clinical Study pc b305/04, to Assess a Longer-term Recurrence Rates in Patients After Hexvix® (Cysview®)Fluorescence Cystoscopy/Turb or White Light Cystoscopy/TURB
Status: Enrolling
Updated: 7/19/2010
Thomas Jefferson Medical College, Department of Neurology
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURB
An Open, Non-interventional, Retrospective, Comparative, Multicenter Follow-up Study in Patients Included in the Previously Completed Clinical Study pc b305/04, to Assess a Longer-term Recurrence Rates in Patients After Hexvix® (Cysview®)Fluorescence Cystoscopy/Turb or White Light Cystoscopy/TURB
Status: Enrolling
Updated:  7/19/2010
Vanderbilt University Medical Center, Department of Urologic Surgery
mi
from
Nashville, TN
Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURB
An Open, Non-interventional, Retrospective, Comparative, Multicenter Follow-up Study in Patients Included in the Previously Completed Clinical Study pc b305/04, to Assess a Longer-term Recurrence Rates in Patients After Hexvix® (Cysview®)Fluorescence Cystoscopy/Turb or White Light Cystoscopy/TURB
Status: Enrolling
Updated: 7/19/2010
Vanderbilt University Medical Center, Department of Urologic Surgery
mi
from
Nashville, TN
Click here to add this to my saved trials
Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURB
An Open, Non-interventional, Retrospective, Comparative, Multicenter Follow-up Study in Patients Included in the Previously Completed Clinical Study pc b305/04, to Assess a Longer-term Recurrence Rates in Patients After Hexvix® (Cysview®)Fluorescence Cystoscopy/Turb or White Light Cystoscopy/TURB
Status: Enrolling
Updated:  7/19/2010
Baylor College of Medicine - Scott Department of Urology
mi
from
Houston, TX
Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURB
An Open, Non-interventional, Retrospective, Comparative, Multicenter Follow-up Study in Patients Included in the Previously Completed Clinical Study pc b305/04, to Assess a Longer-term Recurrence Rates in Patients After Hexvix® (Cysview®)Fluorescence Cystoscopy/Turb or White Light Cystoscopy/TURB
Status: Enrolling
Updated: 7/19/2010
Baylor College of Medicine - Scott Department of Urology
mi
from
Houston, TX
Click here to add this to my saved trials
Measurement of Pro-antiangiogenic Markers in Patients With Hepatic Metastases Undergoing Selective Internal Radiation Therapy (SIRT)
Measurement of Pro-antiangiogenic Markers in Patients With Hepatic Metastases Undergoing Selective Internal Radiation Therapy (SIRT)
Status: Enrolling
Updated:  7/20/2010
Robert Wood Johnson University Hospital
mi
from
New Brunswick, NJ
Measurement of Pro-antiangiogenic Markers in Patients With Hepatic Metastases Undergoing Selective Internal Radiation Therapy (SIRT)
Measurement of Pro-antiangiogenic Markers in Patients With Hepatic Metastases Undergoing Selective Internal Radiation Therapy (SIRT)
Status: Enrolling
Updated: 7/20/2010
Robert Wood Johnson University Hospital
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Measurement of Pro-antiangiogenic Markers in Patients With Hepatic Metastases Undergoing Selective Internal Radiation Therapy (SIRT)
Measurement of Pro-antiangiogenic Markers in Patients With Hepatic Metastases Undergoing Selective Internal Radiation Therapy (SIRT)
Status: Enrolling
Updated:  7/20/2010
The Cancer Institute of New Jersey
mi
from
New Brunswick, NJ
Measurement of Pro-antiangiogenic Markers in Patients With Hepatic Metastases Undergoing Selective Internal Radiation Therapy (SIRT)
Measurement of Pro-antiangiogenic Markers in Patients With Hepatic Metastases Undergoing Selective Internal Radiation Therapy (SIRT)
Status: Enrolling
Updated: 7/20/2010
The Cancer Institute of New Jersey
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
RAD001 in Advanced Hepatocellular Carcinoma
A Phase I/II Study of RAD001 in Advanced Hepatocellular Carcinoma
Status: Enrolling
Updated:  7/22/2010
Massachusetts General Hospital
mi
from
Boston, MA
RAD001 in Advanced Hepatocellular Carcinoma
A Phase I/II Study of RAD001 in Advanced Hepatocellular Carcinoma
Status: Enrolling
Updated: 7/22/2010
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
RAD001 in Advanced Hepatocellular Carcinoma
A Phase I/II Study of RAD001 in Advanced Hepatocellular Carcinoma
Status: Enrolling
Updated:  7/22/2010
Dana-Farber Cancer Institute
mi
from
Boston, MA
RAD001 in Advanced Hepatocellular Carcinoma
A Phase I/II Study of RAD001 in Advanced Hepatocellular Carcinoma
Status: Enrolling
Updated: 7/22/2010
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
RAD001 in Advanced Hepatocellular Carcinoma
A Phase I/II Study of RAD001 in Advanced Hepatocellular Carcinoma
Status: Enrolling
Updated:  7/22/2010
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
RAD001 in Advanced Hepatocellular Carcinoma
A Phase I/II Study of RAD001 in Advanced Hepatocellular Carcinoma
Status: Enrolling
Updated: 7/22/2010
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Evaluating the Effect of Candesartan vs Placebo in Prevention of Trastuzumab-associated Cardiotoxicity
Prospective, Randomized, Pharmacological Intervention Study; Evaluating Effect of the Angiotensin II-receptor (AT1) Blocker Candesartan vs Placebo in Prevention of Trastuzumab-associated Cardiotoxicity in Patients Treated With Trastuzumab
Status: Enrolling
Updated:  7/29/2010
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Evaluating the Effect of Candesartan vs Placebo in Prevention of Trastuzumab-associated Cardiotoxicity
Prospective, Randomized, Pharmacological Intervention Study; Evaluating Effect of the Angiotensin II-receptor (AT1) Blocker Candesartan vs Placebo in Prevention of Trastuzumab-associated Cardiotoxicity in Patients Treated With Trastuzumab
Status: Enrolling
Updated: 7/29/2010
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Pharmacokinetic and Radiation Dosimetry Study Evaluating 99m TC-EC-DG SPECT/CT in Patients With Non-small Cell Lung Cancer (NSCLC)
A Multi-Center Phase 1b Pharmacokinetic and Radiation Dosimetry Study Evaluating 99mTc-EC-DG SPECT/CT in Patients With Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated:  8/4/2010
University of Chicago
mi
from
Chicago, IL
Pharmacokinetic and Radiation Dosimetry Study Evaluating 99m TC-EC-DG SPECT/CT in Patients With Non-small Cell Lung Cancer (NSCLC)
A Multi-Center Phase 1b Pharmacokinetic and Radiation Dosimetry Study Evaluating 99mTc-EC-DG SPECT/CT in Patients With Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated: 8/4/2010
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Pharmacokinetic and Radiation Dosimetry Study Evaluating 99m TC-EC-DG SPECT/CT in Patients With Non-small Cell Lung Cancer (NSCLC)
A Multi-Center Phase 1b Pharmacokinetic and Radiation Dosimetry Study Evaluating 99mTc-EC-DG SPECT/CT in Patients With Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated:  8/4/2010
Mayo Clinic, Division of Nuclear Medicine
mi
from
Rochester, MN
Pharmacokinetic and Radiation Dosimetry Study Evaluating 99m TC-EC-DG SPECT/CT in Patients With Non-small Cell Lung Cancer (NSCLC)
A Multi-Center Phase 1b Pharmacokinetic and Radiation Dosimetry Study Evaluating 99mTc-EC-DG SPECT/CT in Patients With Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated: 8/4/2010
Mayo Clinic, Division of Nuclear Medicine
mi
from
Rochester, MN
Click here to add this to my saved trials
Pharmacokinetic and Radiation Dosimetry Study Evaluating 99m TC-EC-DG SPECT/CT in Patients With Non-small Cell Lung Cancer (NSCLC)
A Multi-Center Phase 1b Pharmacokinetic and Radiation Dosimetry Study Evaluating 99mTc-EC-DG SPECT/CT in Patients With Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated:  8/4/2010
Montefiore Medical Center
mi
from
Bronx, NY
Pharmacokinetic and Radiation Dosimetry Study Evaluating 99m TC-EC-DG SPECT/CT in Patients With Non-small Cell Lung Cancer (NSCLC)
A Multi-Center Phase 1b Pharmacokinetic and Radiation Dosimetry Study Evaluating 99mTc-EC-DG SPECT/CT in Patients With Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated: 8/4/2010
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Phase I Sodium Selenite in Combination With Docetaxel in Castration-resistant Prostate Cancer
A Phase I Study Evaluating the Efficacy and Safety of Sodium Selenite in Combination With Docetaxel in Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  8/19/2010
Stanford University School of Medicine
mi
from
Stanford, CA
Phase I Sodium Selenite in Combination With Docetaxel in Castration-resistant Prostate Cancer
A Phase I Study Evaluating the Efficacy and Safety of Sodium Selenite in Combination With Docetaxel in Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 8/19/2010
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Anatomical Relationship of Level IB Lymph Nodes to the Submandibular Gland in Cancer Patients
Prospective Study to Assess the Anatomical Relationship of Level IB Lymph Nodes to the Submandibular Gland in Patients With Carcinoma of the Upper Aerodigestive Tract
Status: Enrolling
Updated:  8/23/2010
SIU School of Medicine
mi
from
Springfield, IL
Anatomical Relationship of Level IB Lymph Nodes to the Submandibular Gland in Cancer Patients
Prospective Study to Assess the Anatomical Relationship of Level IB Lymph Nodes to the Submandibular Gland in Patients With Carcinoma of the Upper Aerodigestive Tract
Status: Enrolling
Updated: 8/23/2010
SIU School of Medicine
mi
from
Springfield, IL
Click here to add this to my saved trials
Clinical Evaluation of Tissue Sampling Bias in Histologic Evaluation of Sentinel Lymph Nodes in Breast Cancer
Tissue Sampling Bias in Histologic Evaluation of Sentinel Lymph Nodes in Breast Cancer
Status: Enrolling
Updated:  8/27/2010
Breast Care Specialist, PC
mi
from
Allentown, PA
Clinical Evaluation of Tissue Sampling Bias in Histologic Evaluation of Sentinel Lymph Nodes in Breast Cancer
Tissue Sampling Bias in Histologic Evaluation of Sentinel Lymph Nodes in Breast Cancer
Status: Enrolling
Updated: 8/27/2010
Breast Care Specialist, PC
mi
from
Allentown, PA
Click here to add this to my saved trials
Cancer: Thriving and Surviving Online Workshop and Study for Cancer Survivors
Cancer Survivors Online Self-Management Workshop
Status: Enrolling
Updated:  9/8/2010
Stanford University School of Medicine
mi
from
Stanford, CA
Cancer: Thriving and Surviving Online Workshop and Study for Cancer Survivors
Cancer Survivors Online Self-Management Workshop
Status: Enrolling
Updated: 9/8/2010
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Immunotherapy of Melanoma With Tumor Antigen RNA and Small Inhibitory RNA Transfected Autologous Dendritic Cells
Phase I Study of Active Immunotherapy of Metastatic Melanoma With Mature Autologous Dendritic Cells Transfected With Tumor Antigen RNA and Small Inhibitory RNAs to Alter Proteasomal Antigen Processing
Status: Enrolling
Updated:  9/21/2010
Duke Univ Med Ctr
mi
from
Durham, NC
Immunotherapy of Melanoma With Tumor Antigen RNA and Small Inhibitory RNA Transfected Autologous Dendritic Cells
Phase I Study of Active Immunotherapy of Metastatic Melanoma With Mature Autologous Dendritic Cells Transfected With Tumor Antigen RNA and Small Inhibitory RNAs to Alter Proteasomal Antigen Processing
Status: Enrolling
Updated: 9/21/2010
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Multipeptide Vaccine for Advanced Breast Cancer
A Study of hTERT/Survivin Multi-peptide Vaccine With Daclizumab and Prevnar for Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  9/23/2010
University of Pennsylvania Medical Center
mi
from
Philadelphia, PA
Multipeptide Vaccine for Advanced Breast Cancer
A Study of hTERT/Survivin Multi-peptide Vaccine With Daclizumab and Prevnar for Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 9/23/2010
University of Pennsylvania Medical Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Cap Assisted Colonoscopy for the Detection of Colon Polyps
Prospective Randomized Controlled Study of Cap Assisted Colonoscopy for the Detection of Colon Polyps
Status: Enrolling
Updated:  9/28/2010
Veterans Affairs Medical Center
mi
from
Kansas City, MO
Cap Assisted Colonoscopy for the Detection of Colon Polyps
Prospective Randomized Controlled Study of Cap Assisted Colonoscopy for the Detection of Colon Polyps
Status: Enrolling
Updated: 9/28/2010
Veterans Affairs Medical Center
mi
from
Kansas City, MO
Click here to add this to my saved trials
Study Of Ispinesib In Subjects With Breast Cancer
Phase II, Open Label Study of Ispinesib in Subjects With Advanced or Metastatic Breast Cancer
Status: Enrolling
Updated:  10/1/2010
GSK Investigational Site
mi
from
Jacksonville, FL
Study Of Ispinesib In Subjects With Breast Cancer
Phase II, Open Label Study of Ispinesib in Subjects With Advanced or Metastatic Breast Cancer
Status: Enrolling
Updated: 10/1/2010
GSK Investigational Site
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Study Of Ispinesib In Subjects With Breast Cancer
Phase II, Open Label Study of Ispinesib in Subjects With Advanced or Metastatic Breast Cancer
Status: Enrolling
Updated:  10/1/2010
GSK Investigational Site
mi
from
Indianapolis, IN
Study Of Ispinesib In Subjects With Breast Cancer
Phase II, Open Label Study of Ispinesib in Subjects With Advanced or Metastatic Breast Cancer
Status: Enrolling
Updated: 10/1/2010
GSK Investigational Site
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Study Of Ispinesib In Subjects With Breast Cancer
Phase II, Open Label Study of Ispinesib in Subjects With Advanced or Metastatic Breast Cancer
Status: Enrolling
Updated:  10/1/2010
GSK Investigational Site
mi
from
Chapel Hill, NC
Study Of Ispinesib In Subjects With Breast Cancer
Phase II, Open Label Study of Ispinesib in Subjects With Advanced or Metastatic Breast Cancer
Status: Enrolling
Updated: 10/1/2010
GSK Investigational Site
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Study Of Ispinesib In Subjects With Breast Cancer
Phase II, Open Label Study of Ispinesib in Subjects With Advanced or Metastatic Breast Cancer
Status: Enrolling
Updated:  10/1/2010
GSK Investigational Site
mi
from
Pittsburgh, PA
Study Of Ispinesib In Subjects With Breast Cancer
Phase II, Open Label Study of Ispinesib in Subjects With Advanced or Metastatic Breast Cancer
Status: Enrolling
Updated: 10/1/2010
GSK Investigational Site
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Study Of Ispinesib In Subjects With Breast Cancer
Phase II, Open Label Study of Ispinesib in Subjects With Advanced or Metastatic Breast Cancer
Status: Enrolling
Updated:  10/1/2010
GSK Investigational Site
mi
from
Bruxelles,
Study Of Ispinesib In Subjects With Breast Cancer
Phase II, Open Label Study of Ispinesib in Subjects With Advanced or Metastatic Breast Cancer
Status: Enrolling
Updated: 10/1/2010
GSK Investigational Site
mi
from
Bruxelles,
Click here to add this to my saved trials
Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer
A Phase II, Open-Label Study of Ispinesib in Subjects With Platinum/Taxane-Refractory or Resistant Relapsed Ovarian Cancer
Status: Enrolling
Updated:  10/1/2010
GSK Investigational Site
mi
from
Birmingham, AL
Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer
A Phase II, Open-Label Study of Ispinesib in Subjects With Platinum/Taxane-Refractory or Resistant Relapsed Ovarian Cancer
Status: Enrolling
Updated: 10/1/2010
GSK Investigational Site
mi
from
Birmingham, AL
Click here to add this to my saved trials
Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer
A Phase II, Open-Label Study of Ispinesib in Subjects With Platinum/Taxane-Refractory or Resistant Relapsed Ovarian Cancer
Status: Enrolling
Updated:  10/1/2010
GSK Investigational Site
mi
from
New Orleans, LA
Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer
A Phase II, Open-Label Study of Ispinesib in Subjects With Platinum/Taxane-Refractory or Resistant Relapsed Ovarian Cancer
Status: Enrolling
Updated: 10/1/2010
GSK Investigational Site
mi
from
New Orleans, LA
Click here to add this to my saved trials
Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer
A Phase II, Open-Label Study of Ispinesib in Subjects With Platinum/Taxane-Refractory or Resistant Relapsed Ovarian Cancer
Status: Enrolling
Updated:  10/1/2010
GSK Investigational Site
mi
from
St. Louis, MO
Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer
A Phase II, Open-Label Study of Ispinesib in Subjects With Platinum/Taxane-Refractory or Resistant Relapsed Ovarian Cancer
Status: Enrolling
Updated: 10/1/2010
GSK Investigational Site
mi
from
St. Louis, MO
Click here to add this to my saved trials
Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer
A Phase II, Open-Label Study of Ispinesib in Subjects With Platinum/Taxane-Refractory or Resistant Relapsed Ovarian Cancer
Status: Enrolling
Updated:  10/1/2010
GSK Investigational Site
mi
from
Mayfield Heights, OH
Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer
A Phase II, Open-Label Study of Ispinesib in Subjects With Platinum/Taxane-Refractory or Resistant Relapsed Ovarian Cancer
Status: Enrolling
Updated: 10/1/2010
GSK Investigational Site
mi
from
Mayfield Heights, OH
Click here to add this to my saved trials
Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer
A Phase II, Open-Label Study of Ispinesib in Subjects With Platinum/Taxane-Refractory or Resistant Relapsed Ovarian Cancer
Status: Enrolling
Updated:  10/1/2010
GSK Investigational Site
mi
from
Oklahoma City, OK
Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer
A Phase II, Open-Label Study of Ispinesib in Subjects With Platinum/Taxane-Refractory or Resistant Relapsed Ovarian Cancer
Status: Enrolling
Updated: 10/1/2010
GSK Investigational Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer
A Phase II, Open-Label Study of Ispinesib in Subjects With Platinum/Taxane-Refractory or Resistant Relapsed Ovarian Cancer
Status: Enrolling
Updated:  10/1/2010
GSK Investigational Site
mi
from
Abington, PA
Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer
A Phase II, Open-Label Study of Ispinesib in Subjects With Platinum/Taxane-Refractory or Resistant Relapsed Ovarian Cancer
Status: Enrolling
Updated: 10/1/2010
GSK Investigational Site
mi
from
Abington, PA
Click here to add this to my saved trials
Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer
A Phase II, Open-Label Study of Ispinesib in Subjects With Platinum/Taxane-Refractory or Resistant Relapsed Ovarian Cancer
Status: Enrolling
Updated:  10/1/2010
GSK Investigational Site
mi
from
Nashville, TN
Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer
A Phase II, Open-Label Study of Ispinesib in Subjects With Platinum/Taxane-Refractory or Resistant Relapsed Ovarian Cancer
Status: Enrolling
Updated: 10/1/2010
GSK Investigational Site
mi
from
Nashville, TN
Click here to add this to my saved trials
Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer
A Phase II, Open-Label Study of Ispinesib in Subjects With Platinum/Taxane-Refractory or Resistant Relapsed Ovarian Cancer
Status: Enrolling
Updated:  10/1/2010
GSK Investigational Site
mi
from
Seattle, WA
Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer
A Phase II, Open-Label Study of Ispinesib in Subjects With Platinum/Taxane-Refractory or Resistant Relapsed Ovarian Cancer
Status: Enrolling
Updated: 10/1/2010
GSK Investigational Site
mi
from
Seattle, WA
Click here to add this to my saved trials
Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer
A Phase II, Open-Label Study of Ispinesib in Subjects With Platinum/Taxane-Refractory or Resistant Relapsed Ovarian Cancer
Status: Enrolling
Updated:  10/1/2010
GSK Investigational Site
mi
from
Madison, WI
Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer
A Phase II, Open-Label Study of Ispinesib in Subjects With Platinum/Taxane-Refractory or Resistant Relapsed Ovarian Cancer
Status: Enrolling
Updated: 10/1/2010
GSK Investigational Site
mi
from
Madison, WI
Click here to add this to my saved trials
Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors
High-Dose Chemotherapy With Tandem Peripheral Blood Stem Cell (PBSC) Rescue for the Treatment of High-Risk Pediatric Solid Tumors.
Status: Enrolling
Updated:  10/7/2010
Children's Memorial Hospital
mi
from
Chicago, IL
Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors
High-Dose Chemotherapy With Tandem Peripheral Blood Stem Cell (PBSC) Rescue for the Treatment of High-Risk Pediatric Solid Tumors.
Status: Enrolling
Updated: 10/7/2010
Children's Memorial Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Extracorporeal Photopheresis for Acute Graft Versus Host Disease
Extracorporeal Photopheresis for Steroid-refractory Acute GVHD in Children and Young Adults: a Safety and Feasibility Study.
Status: Enrolling
Updated:  10/7/2010
Children's Memorial Hospital
mi
from
Chicago, IL
Extracorporeal Photopheresis for Acute Graft Versus Host Disease
Extracorporeal Photopheresis for Steroid-refractory Acute GVHD in Children and Young Adults: a Safety and Feasibility Study.
Status: Enrolling
Updated: 10/7/2010
Children's Memorial Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Trail of Taxotere Plus Sunitinib on Newly Diagnosed, Hormone Refractory, Metastatic Prostate Cancer
A Pilot Phase II Study to Determine the Effects of Taxotere Plus Sunitinib on Newly Diagnosed, Hormone Refractory, Symptomatic and Asymptomatic, Metastatic Prostate Cancer Who Are Chemotherapy-naïve.
Status: Enrolling
Updated:  10/11/2010
Chao Comprehensive Cancer Center
mi
from
Orange, CA
Trail of Taxotere Plus Sunitinib on Newly Diagnosed, Hormone Refractory, Metastatic Prostate Cancer
A Pilot Phase II Study to Determine the Effects of Taxotere Plus Sunitinib on Newly Diagnosed, Hormone Refractory, Symptomatic and Asymptomatic, Metastatic Prostate Cancer Who Are Chemotherapy-naïve.
Status: Enrolling
Updated: 10/11/2010
Chao Comprehensive Cancer Center
mi
from
Orange, CA
Click here to add this to my saved trials
Comparison of Traditional and Echocardiography Guided Fluid Management During Cytoreductive Surgery With HIPEC
Comparison of Traditional (Central Venous Pressure (CVP) and Urine Output Guided) Versus Echocardiography Guided Fluid Management in Patients Undergoing Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
Status: Enrolling
Updated:  10/19/2010
Nebraska Medical Center
mi
from
Omaha, NE
Comparison of Traditional and Echocardiography Guided Fluid Management During Cytoreductive Surgery With HIPEC
Comparison of Traditional (Central Venous Pressure (CVP) and Urine Output Guided) Versus Echocardiography Guided Fluid Management in Patients Undergoing Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
Status: Enrolling
Updated: 10/19/2010
Nebraska Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
A Study of Cesium-131 Brachytherapy Following Sub-Lobar Resection for Early Stage Non Small Cell Lung Cancer
Outcome Study of Cesium-131 Brachytherapy Following Sub-Lobar Resection for Early Stage NSCLC
Status: Enrolling
Updated:  11/8/2010
Weill-Cornell Medical College
mi
from
New York, NY
A Study of Cesium-131 Brachytherapy Following Sub-Lobar Resection for Early Stage Non Small Cell Lung Cancer
Outcome Study of Cesium-131 Brachytherapy Following Sub-Lobar Resection for Early Stage NSCLC
Status: Enrolling
Updated: 11/8/2010
Weill-Cornell Medical College
mi
from
New York, NY
Click here to add this to my saved trials